KIDS Stock Analysis: Buy, Sell, or Hold?
KIDS - OrthoPediatrics Corp. Common Stock
$19.14
0.77 (4.16%)
▲
5d:
+3.29%
30d:
+4.19%
90d:
+20.3%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When KIDS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: KIDS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: KIDS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: KIDS is currently trading at $19.14, which is considered extended relative to its 30-day fair value range of $17.45 to $18.64.
Technical Outlook: Technically, KIDS is in a uptrend. The price is approaching resistance at $19.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: KIDS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.67 (+28.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KIDS is in a uptrend. The price is approaching resistance at $19.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: KIDS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.67 (+28.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.45 -
$18.64
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 28.9% below Wall St target ($24.67)
Trading Range Analysis
30-Day Trading Range
$17.45 -
$18.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.64
Resistance Level
$19.27
Current Trend
Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-28.15
Wall Street Target
$24.67
(+28.9%)
Revenue Growth (YoY)
13.3%
Profit Margin
-16.3%
Share & Embed Analysis
Last updated: June 25, 2026 3:10 AM ET
Data refreshes hourly during market hours. Next update: 4:10 AM
Data refreshes hourly during market hours. Next update: 4:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KIDS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Daniel J Gerritzen
SELL
8614 shares
2026-03-16
David R Bailey
SELL
19535 shares
2026-03-16
Fred Hite
SELL
12993 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 65 BUY |
